What Isthe Physician Payments Sunshine Act Or Open Payments
Download What Isthe Physician Payments Sunshine Act Or Open Payments full books in PDF, epub, and Kindle. Read online free What Isthe Physician Payments Sunshine Act Or Open Payments ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Abraham Gitterman |
Publisher | : |
Total Pages | : 124 |
Release | : 2016-04-07 |
Genre | : Law |
ISBN | : 9781634252911 |
The Sunshine Act requires applicable manufacturers of drugs, biologics, devices, or medical supplies covered under Medicare, Medicaid, or the Children's Health Insurance Plan (CHIP) to report annually to the Centers for Medicare and Medicaid Services (CMS) in an electronic format, payments or transfers of value made to "covered recipients"--physicians and teaching hospitals.
Author | : |
Publisher | : |
Total Pages | : 6 |
Release | : 2014 |
Genre | : |
ISBN | : |
New regulations require medical product manufacturers to publicly report payments made to physicians and teaching hospitals.
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 436 |
Release | : 2009-09-16 |
Genre | : Medical |
ISBN | : 0309145449 |
Collaborations of physicians and researchers with industry can provide valuable benefits to society, particularly in the translation of basic scientific discoveries to new therapies and products. Recent reports and news stories have, however, documented disturbing examples of relationships and practices that put at risk the integrity of medical research, the objectivity of professional education, the quality of patient care, the soundness of clinical practice guidelines, and the public's trust in medicine. Conflict of Interest in Medical Research, Education, and Practice provides a comprehensive look at conflict of interest in medicine. It offers principles to inform the design of policies to identify, limit, and manage conflicts of interest without damaging constructive collaboration with industry. It calls for both short-term actions and long-term commitments by institutions and individuals, including leaders of academic medical centers, professional societies, patient advocacy groups, government agencies, and drug, device, and pharmaceutical companies. Failure of the medical community to take convincing action on conflicts of interest invites additional legislative or regulatory measures that may be overly broad or unduly burdensome. Conflict of Interest in Medical Research, Education, and Practice makes several recommendations for strengthening conflict of interest policies and curbing relationships that create risks with little benefit. The book will serve as an invaluable resource for individuals and organizations committed to high ethical standards in all realms of medicine.
Author | : United States. Congress. Senate. Special Committee on Aging |
Publisher | : |
Total Pages | : 152 |
Release | : 2013 |
Genre | : Conflict of interests |
ISBN | : |
Author | : Jerome P. Kassirer M.D. |
Publisher | : Oxford University Press |
Total Pages | : 272 |
Release | : 2004-10-18 |
Genre | : Medical |
ISBN | : 0198039298 |
We all know that doctors accept gifts from drug companies, ranging from pens and coffee mugs to free vacations at luxurious resorts. But as the former Editor-in-Chief of The New England Journal of Medicine reveals in this shocking expose, these innocuous-seeming gifts are just the tip of an iceberg that is distorting the practice of medicine and jeopardizing the health of millions of Americans today. In On the Take, Dr. Jerome Kassirer offers an unsettling look at the pervasive payoffs that physicians take from big drug companies and other medical suppliers, arguing that the billion-dollar onslaught of industry money has deflected many physicians' moral compasses and directly impacted the everyday care we receive from the doctors and institutions we trust most. Underscored by countless chilling untold stories, the book illuminates the financial connections between the wealthy companies that make drugs and the doctors who prescribe them. Kassirer details the shocking extent of these financial enticements and explains how they encourage bias, promote dangerously misleading medical information, raise the cost of medical care, and breed distrust. Among the questionable practices he describes are: the disturbing number of senior academic physicians who have financial arrangements with drug companies; the unregulated "front" organizations that advocate certain drugs; the creation of biased medical education materials by the drug companies themselves; and the use of financially conflicted physicians to write clinical practice guidelines or to testify before the FDA in support of a particular drug. A brilliant diagnosis of an epidemic of greed, On the Take offers insight into how we can cure the medical profession and restore our trust in doctors and hospitals.
Author | : John Kasprak |
Publisher | : |
Total Pages | : |
Release | : 2007 |
Genre | : Conflict of interests |
ISBN | : |
Discusses recently proposed federal legislation that addresses payments made by pharmaceutical companies to physicians.
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 235 |
Release | : 2018-03-01 |
Genre | : Medical |
ISBN | : 0309468086 |
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author | : United States. Physician Payment Review Commission |
Publisher | : |
Total Pages | : 122 |
Release | : 1987 |
Genre | : Medical fees |
ISBN | : |
Author | : California |
Publisher | : |
Total Pages | : 58 |
Release | : 1913 |
Genre | : Pharmacy |
ISBN | : |
Author | : OECD |
Publisher | : OECD Publishing |
Total Pages | : 306 |
Release | : 2017-01-10 |
Genre | : |
ISBN | : 9264266410 |
Countries could potentially spend significantly less on health care with no impact on health system performance, or on health outcomes. This report reviews strategies put in place by countries to limit ineffective spending and waste.